Evidence map›Paper›PMID 39676357›Full record

ArticleThe Journal of law, medicine & ethics : a journal of the American Society of Law, Medicine & Ethics2024

Biopreserving Pathogens: Promise & Peril.

Justyna Jaskiewicz, Susan M Wolf, Mehmet Toner, Rebecca D Sandlin

Abstract read
PubMed Full text at PMC Publisher
In one paragraph

Article in The Journal of law, medicine & ethics : a journal of the American Society of Law, Medicine & Ethics, 2024. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 2 papers.

0numbers the graph read from it
0cells of the map it votes in
2citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

2 citing papers in PubMed.

  1. Biobanking biodiversity: recent strategies, challenges, and opportunities.The Journal of reproduction and development · 2026
    Review
  2. The Journal of law, medicine & ethics : a journal of the American Society of Law, Medicine & Ethics · 2024
    Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

4 authors.

Justyna JaskiewiczMASSACHUSETTS GENERAL HOSPITAL, HARVARD MEDICAL SCHOOL, AND SHRINERS CHILDREN'S BOSTON, BOSTON, MASSACHUSETTS, USA.ORCID 0000-0002-0271-3405
Susan M WolfUNIVERSITY OF MINNESOTA, MINNEAPOLIS, MINNESOTA, USA.
Mehmet TonerMASSACHUSETTS GENERAL HOSPITAL, HARVARD MEDICAL SCHOOL, AND SHRINERS CHILDREN'S BOSTON, BOSTON, MASSACHUSETTS, USA.
Rebecca D SandlinMASSACHUSETTS GENERAL HOSPITAL, HARVARD MEDICAL SCHOOL, AND SHRINERS CHILDREN'S BOSTON, BOSTON, MASSACHUSETTS, USA.

Funding

Optimizing and expanding cryopreservation of Cryptosporidium oocystsR21AI154026 · NIAID · MASSACHUSETTS GENERAL HOSPITAL · PI SANDLIN, REBECCA, TZIPORI, SAUL R · 2020 to 2021
$475k
National Science Foundation EEC 1941543NIAID NIH HHS R21 AI154026
6 · The paper itself

Abstract

The development of technologies for the biopreservation of infectious organisms requires careful analysis of benefits and risks. This article reviews the regulatory landscape and oversight responsibilities in the United States in respect to pathogen biopreservation. Focused on two globally significant pathogens,

Indexed as

CryptosporidiumAnimalsContainment of BiohazardsGovernment RegulationHumansMalariaPlasmodiumUnited StatesBiopreservationBioterrorismCryopreservationDual UseEthicsPathogen

Identifiers

PMID39676357
PMCPMC12924624

What OpenQuestion holds

Textmetadata
LicenceTDM
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.